The FDA has granted tentative approval for Admelog (insulin lispro injection) 100 Units/mL, a rapid-acting human insulin analog, from Sanofi....
Sanofi announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted...
For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Insulin lispro Sanofi is also indicated for the initial stabilisation of diabetes mellitus.
FDA approves Admelog for diabetes
For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Admelog is also indicated for the initial stabilisation of diabetes mellitus.